NCT/Study#
NCT04628767 /
EA8192
A Phase II/III Trial Of MEDI4736 (Durvalumab) And Chemotherapy For Patients With High Grade Upper Tract Urothelial Cancer Prior To Nephroureterectomy
DISEASE GROUP:
Genito-Urinary
current phase:
Phase II/III
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
